Try our Advanced Search for more refined results
Searching dockets in American Academy Of Ophthalmology x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Personal Inj. Med. Malpractice | California Central
Continue
EX PARTE APPLICATION to Continue PRETRIAL DEADLINES AND TRIAL OR IN THE ALTERNATIVE TO ADVANCE THE HEARING DATE ON MOTION TO AMEND SCHEDULING ORDER Re: NOTICE OF MOTION AND MOTION to AMEND Text Only Scheduling Notice, 103 118 filed by Defendant Mehryar Ray Taban, MD. (Attachments: # 1 Declaration OF CHAENA DADE IN SUPPORT OF DEFENDANT MEHRYAR TABAN, MDS EX PARTE APPLICATION TO CONTINUE PRETRIAL DEADLINES AND TRIAL OR IN THE ALTERNATIVE TO ADVANCE THE HEARING DATE ON MOTION TO AMEND SCHEDULING ORDER, # 2 Proposed Order) (Dade, Chaena)
Amend/Correct
NOTICE OF MOTION AND MOTION to AMEND Text Only Scheduling Notice, 103 filed by Defendant Mehryar Ray Taban, MD. Motion set for hearing on 7/20/2026 at 01:30 PM before Judge Stephen V. Wilson. (Attachments: # 1 Declaration OF CHAENA B. DADE, ESQ., IN SUPPORT OF DEFENDANT MEHRYAR TABAN, MDS MOTION TO AMEND SCHEDULING ORDER, # 2 Proposed Order) (Dade, Chaena)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.